Provides that pharmacy benefits managers have fiduciary duty to financial interests of covered persons.
Impact
The implications of SB378 are notable as it amends existing statutes regarding pharmacy benefit management. By expressly mandating that PBMs act in good faith and fair dealing towards covered persons, the legislation is designed to safeguard against potential malpractice where the financial interests of those receiving healthcare benefits could be compromised. The bill also seeks to ensure that cost-sharing requirements for prescription drugs do not exceed what patients would pay if they purchased their medications outright, which could potentially lower healthcare costs for consumers.
Summary
Senate Bill 378 introduces significant changes to the role of pharmacy benefits managers (PBMs) in New Jersey by imposing a fiduciary duty on them towards covered persons. This legal obligation requires PBMs to prioritize the financial interests of individuals they serve—namely, those covered under health benefits plans—over the interests of the health insurance carriers with whom they contract. The bill highlights the importance of accountability in the management of pharmacy benefits and aims to enhance consumer protections within the healthcare system.
Contention
While the bill is aimed at increasing transparency and accountability within the pharmacy benefits supply chain, some stakeholders may argue that additional regulations could burden PBMs and health carriers with increased compliance costs. Critics might contend that setting such fiduciary duties may complicate the existing operational frameworks of PBMs and lead to unintended consequences, such as higher insurance costs in the long run or challenges in maintaining adequate retail pharmacy networks. The balance between consumer protection and the operational viability of pharmacy benefit management is likely to be a point of significant discussion as the bill moves forward.